Overview
- 6 FDA inspections are on record.
- 2 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-06-02.
At a glance
Inspections
6
Form 483s
2
EIRs
1
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 27 May 2026 – 2 Jun 2026 | Human Drugs | Clean | |
| 24 Oct 2022 – 31 Oct 2022 | Human Drugs | Clean | |
| 19 Sep 2018 – 26 Sep 2018 | Human Drugs | 483 | View 483 → |
| 17 Jun 2015 – 24 Jun 2015 | Human Drugs | 483 | View 483 → |
| 30 Mar 2012 | Not recorded | Clean | |
| 27 Sep 2010 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
24 Jun 2015
21 CFR 211.100(b)
SOPs not followed / documented
Cited by Walden H Lee, William J Leonard, Cassandra L Abellard
Investigators
FDA investigators tied to this site in the record.
Margaret M Annes2 insp.
Oluwasefunm Agbanigo1 insp.
Dorothy P Kramer1 insp.
Christopher N Tran1 insp.
Francis A Guidry1 insp.
Walden H Lee1 insp.
William J Leonard1 insp.
Cassandra L Abellard1 insp.
Jocelyn C Turner1 insp.
Tonya R Johnson1 insp.
Lloyd D Payne1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.194(a)(8) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.113(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.80(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Avara Pharmaceutical Technologies, Inc.'s 2 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat